Clinical Trial Update: Gemcitabine in Long Infusion and Cisplatin for Malignant Pleural Mesothelioma Treatment [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating long-infusion gemcitabine with cisplatin in malignant pleural mesothelioma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Mesothelioma

Drugs mentioned

• Gemzar (gemcitabine)
• Platinol (cisplatin)

Snippet

Sponsor: Institute of Oncology Ljubljana | Conditions: Malignant Pleural Mesothelioma | Phase 2 | Status: COMPLETED